Skip to content

Drug interactions

Fingolimod + Octreotide

Severity: Moderate

Fingolimod and Octreotide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Octreotide can cause bradycardia and QT prolongation, and fingolimod also slows heart rate and may affect QT. The combination may increase the risk of arrhythmia, particularly in patients with heart disease or electrolyte disturbances.

What this interaction means in plain words

Fingolimod and Octreotide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Fingolimod belongs to Central Nervous System; Octreotide belongs to Endocrine.

Evidence level: Low

Why it happens

Additive bradycardic and QT-prolonging effects.

What to do

Obtain a baseline ECG and monitor heart rate and ECG after fingolimod initiation; correct potassium and magnesium abnormalities.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Fingolimod and Octreotide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Fingolimod with Octreotide?

MediHelp rates the interaction as moderate. Fingolimod and Octreotide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Octreotide can cause bradycardia and QT prolongation, and fingolimod also slows heart rate and may affect QT. The combination may increase the risk of arrhythmia, particularly in patients with heart disease or electrolyte disturbances.

How serious is the interaction between Fingolimod and Octreotide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain a baseline ECG and monitor heart rate and ECG after fingolimod initiation; correct potassium and magnesium abnormalities.

What other medicines interact with Fingolimod?

MediHelp also lists interactions of Fingolimod with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Pimozide. The full list is on the Fingolimod page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in